Skip to main content
SpringerLink
Log in

Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Peripheral blood (PBL) and synovial fluid lymphocytes (SFL) from 18 patients with definite rheumatoid arthritis (RA) and from one patient with Reiter's disease (RD) were examined for their capacity to absorb quantitatively interleukin-2 (IL-2) from a standardized, lectin-free IL-2 source. For comparison normal ConA blasts and PBL from various inflammatory and noninflammatory diseases as well as from healthy control persons were studied. IL-2 activity was quantitated by measuring 3H-thymidine-2-deoxyriboside uptake in the IL-2 dependent murine T cell line CTL6. ConA blasts exhibited a high IL-2 absorption capacity and served as a positive control for calibrating the absorption assay. In a population of normal PBL at least 5–10% of ConA blasts were required to detect IL-2 absorption. Significant absorption was assumed if more than 50% of IL-2 activity was removed from 200 μl of a lectin-free IL-2 standard following incubation with 5 × 106 lymphoid cells for 2 h at 4°C; this criterion was fulfilled with 8 out of 20 SFL and 4 out of 14 PBL preparations from RA patients. As a rule SFL absorbed more IL-2 than PBL. Control PBL did not absorb significant quantities of IL-2. PBL from the RD patient apparently produced an IL-2 inhibitor during incubation with the IL-2 standard. IL-2 absorption by ConA blasts and SFL was fully inhibited by preincubation of the absorbing cells with monoclonal anti-TAC antibody, a reagent known to react with the human IL-2 receptor. The results are discussed in view of current concepts of antigen/mitogen induced T cell activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Paetkau V, Mills G, Gerhart S, Monticone V (1976) Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator). J Immunol 117:1320–1324

    Google Scholar 

  2. Wagner H, Röllinghoff M (1978) T-T cell interactions during in vitro cytotoxic allograft response. I. Soluble products from Ly1 + T cells trigger autonomously antigen primed Ly23+ T cells to cell proliferation and cytotoxic activity. J Exp Med 148:1523–1538

    Google Scholar 

  3. Wagner H, Röllinghoff M, Kurrle R, Seiler FR (eds) (1980) “Interleukin-2”. Behring Inst Mitt 67

  4. Robb RJ, Munck A, Smith KA (1984) T cell growth factor receptors — quantitation, specificity, and biological relevance. J Exp Med 154:1455–1474

    Google Scholar 

  5. Palacios R (1982) Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev 63:73–110

    Google Scholar 

  6. Stadler BM, Farrar JJ, Oppenheim JJ (1980) Cell cycle dependent productions of human interleukin-2. Behring Inst Mitt 67:245–248

    Google Scholar 

  7. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA (1983) Defective production of IL-1 and IL-2 in patients with SLE. J Immunol 130:2651–2655

    Google Scholar 

  8. Lopez-Botet M, Fontan G, Rodriguez MCG, De Landazuri MO (1983) Relationship between IL-2 synthesis and the proliferative response to PHA in different primary immunodeficiencies. J Immunol 128:679–683

    Google Scholar 

  9. Peter HH, Gronewold P, Kirchner H, Northoff H (1983) Lymphokine productions in common varied immunodeficiency, polyclonal hypergammaglobulinemia, and granulomatous diseases. In: Oppenheim JJ, Cohen S (eds) Interleukins, lymphokines and cytokines. Academic Press, London, pp 677–685

    Google Scholar 

  10. Bonnard GD, Yasaka K, Jacobson D (1979) Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cell. J Immunol 123:2704–2708

    Google Scholar 

  11. Röllinghoff M, Scheurich P, Hardt C, Pfizenmaier K (1983) Analysis of interleukin-2 receptor sites on activated T cells. Behring Inst Mitt 72:67–72

    Google Scholar 

  12. Ropez MW, Bennett GA, Cobb S, Jacox R, Jessar R (1958) 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176

    Google Scholar 

  13. Uchiyama T, Nelson DL, Fleischer TA, Waldman TA (1981) A monoclonal antibody (anti-TAC) reactive with activated and functionally mature human T cells. II. Expressions of TAC antigen on activated cytotoxic killer T cells, suppressor cells and on one of two types of helper T cells. J Immunol 126:1398–1403

    Google Scholar 

  14. Depper JM, Leonhard WJ, Robb RJ, Waldman TA, Greene WC (1983) Blockade of the interleukin-2 receptor by anti-TAC antibody: inhibition of human lymphocyte activation. J Immunol 131:690–696

    Google Scholar 

  15. Gillis S, Ferm MM, Ou W, Smith KA (1978) Parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032

    Google Scholar 

  16. Smith KA (1980) T cell growth factor. Immunol Rev 51:337–356

    Google Scholar 

  17. Farrar J, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J (1982) The biochemistry, biology, and role of interleukin-2 in the induction of cytotoxic T cell and antibody forming B cell responses. Immunol Rev 63:129–166

    Google Scholar 

  18. Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MAS (1982) Purification of human interleukin-2 to apparent homogeneity and its molecular heterogeneity. J Exp Med 156:454–464

    Google Scholar 

  19. Mühlradt PF, Opitz HG (1982) Clearance of interleukin-2 from the blood of normal and t cell depleted mice. Eur J Immunol 12:983–985

    Google Scholar 

  20. Donohue JH, Rosenberg SA (1983) The fate of interleukin-2 after in vivo administration. J Immunol 130:2203–2208

    Google Scholar 

  21. Flomenberg N, Welte K, Mertelsmann R, Kernan N, Ciobanu N, Venuta S, Feldman S, Kruger G, Kirkpatrick D, Dupont B, O'Reilly R (1983) Immunologic effects of interleukin-2 in primary immunodeficiency diseases. J Immunol 130:2644–2650

    Google Scholar 

  22. Dopfer R, Niethammer D, Peter HH, Kniep EM, Monner DA, Mühlradt PF (1984) In vivo effects of interleukin-2 on lymphocyte subpopulations in a patient with a combined immunodeficiency. Immunobiology 167:452–461

    Google Scholar 

  23. Yachie A, Miyawaki T, Uwadana N, Ohzeki S, Tanigushi N (1983) Sequential expression of T cell activation (TAC) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid. J Immunol 131:731–735

    Google Scholar 

  24. Burmester GR, Yu DTY, Irani AM, Kunkel HG, Winchester RJ (1981) Ia+ T cells in synovial fluid and tissue of patients with rheumatoid arthritis. Arthritis Rheum 24:1370–1376

    Google Scholar 

  25. Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan J (1982) Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 128:351–354

    Google Scholar 

  26. Duclos M, Zeidler H, Liman W, Pichler WJ, Rieber P, Peter HH (1982) Characterization of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining. Rheumatol Int 2:75–82

    Google Scholar 

  27. Burmester GR, Jahn B, Gramatzki M, Zacher J, Kalden JR (1984) Activated T cells in vivo and in vitro: Divergence in expression of TAC and Ia antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro. J Immunol 133:1230–1234

    Google Scholar 

  28. Robb RJ, Green WC, Rusk CM (1984) Low and high affinity receptors for interleukin 2. J Exp Med 160:1126–1146

    Google Scholar 

  29. Schlesier M, Ramb CH, Peter HH (1984) Characterization of cloned T lymphocytes from blood and synovial fluid of a patient with rheumatoid arthritis. Clin Rheumatol 3:87 (Abstr)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Immunologie und Transfusionsmedizin, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, D-3000, Hannover 61, Federal Republic of Germany

    C. Knobloch, M. Schlesier, R. Dräger & M. Gärtner

  2. Abteilung Rheumatologie und klinische Immunologie, Medizinische Universitätsklinik, Hugstetter Straße 55, D-7800, Freiburg, Federal Republic of Germany

    H. H. Peter

Authors
  1. C. Knobloch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schlesier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Gärtner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. H. Peter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knobloch, C., Schlesier, M., Dräger, R. et al. Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis. Rheumatol Int 5, 133–139 (1985). https://doi.org/10.1007/BF00541333

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541333

Key words

Search

Navigation